BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36090458)

  • 1. Case report of elevation of high-sensitivity cardiac troponin T in the absence of cardiac involvement in immune checkpoint inhibitor-associated myositis.
    Ruperti-Repilado FJ; van der Stouwe JG; Haaf P; Mueller C; Läubli H; Pfister O; Rothschild SI; Kuster GM
    Eur Heart J Case Rep; 2022 Sep; 6(9):ytac353. PubMed ID: 36090458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report.
    Monge C; Maeng H; Brofferio A; Apolo AB; Sathya B; Arai AE; Gulley JL; Bilusic M
    J Immunother Cancer; 2018 Dec; 6(1):150. PubMed ID: 30563577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of troponin T versus I in the diagnosis of immune checkpoint inhibitor-related myocarditis and myositis: rechallenge?
    Rossi VA; Gawinecka J; Dimitriou F; von Eckardstein A; Dummer R; Ruschitzka F; Matter CM
    ESC Heart Fail; 2023 Aug; 10(4):2680-2685. PubMed ID: 37021424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma.
    Matsui H; Kawai T; Sato Y; Ishida J; Kadowaki H; Akiyama Y; Yamada Y; Nakamura M; Yamada D; Akazawa H; Suzuki M; Komuro I; Kume H
    Int Heart J; 2020 Sep; 61(5):1070-1074. PubMed ID: 32921673
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Boughdad S; Latifyan S; Fenwick C; Bouchaab H; Suffiotti M; Moslehi JJ; Salem JE; Schaefer N; Nicod-Lalonde M; Costes J; Perreau M; Michielin O; Peters S; Prior JO; Obeid M
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34686542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Checkpoint Inhibitor-Related Myositis Overlapping With Myocarditis: An Institutional Case Series and a Systematic Review of Literature.
    Nakagomi Y; Tajiri K; Shimada S; Li S; Inoue K; Murakata Y; Murata M; Sakai S; Sato K; Ieda M
    Front Pharmacol; 2022; 13():884776. PubMed ID: 35645839
    [No Abstract]   [Full Text] [Related]  

  • 7. Asymptomatic Myocarditis with Mild Cardiac Marker Elevation Following Nivolumab-Induced Myositis.
    Shindo A; Yamasaki M; Uchino K; Yamasaki M
    Int Heart J; 2022; 63(1):180-183. PubMed ID: 35095069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Troponin I and T in Checkpoint Inhibitor-associated Myositis and Myocarditis.
    Ang E; Mweempwa A; Heron C; Ahn Y; Rivalland G; Ha LY; Deva S
    J Immunother; 2021 May; 44(4):162-163. PubMed ID: 33416262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction.
    Rittoo D; Jones A; Lecky B; Neithercut D
    J Am Coll Cardiol; 2014 Jun; 63(22):2411-20. PubMed ID: 24747102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report.
    Delombaerde D; Vervloet D; Berwouts D; Beckers R; Prenen H; Peeters M; Gremonprez F; Croes L; Vulsteke C
    J Med Case Rep; 2022 Jul; 16(1):275. PubMed ID: 35831829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series.
    Vicino A; Hottinger AF; Latifyan S; Boughdad S; Becce F; Prior JO; Kuntzer T; Brouland JP; Dunet V; Obeid M; Théaudin M
    J Neurol; 2024 Apr; 271(4):1947-1958. PubMed ID: 38141128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
    Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G
    Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case report of immune checkpoint inhibitor-related steroid-refractory myocarditis and myasthenia gravis-like myositis treated with abatacept and mycophenolate mofetil.
    Jespersen MS; Fanø S; Stenør C; Møller AK
    Eur Heart J Case Rep; 2021 Nov; 5(11):ytab342. PubMed ID: 34870082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoldering myocarditis following immune checkpoint blockade.
    Norwood TG; Westbrook BC; Johnson DB; Litovsky SH; Terry NL; McKee SB; Gertler AS; Moslehi JJ; Conry RM
    J Immunother Cancer; 2017 Nov; 5(1):91. PubMed ID: 29157297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pembrolizumab-induced myocarditis with complete atrioventricular block and concomitant myositis in a metastatic bladder cancer patient: a case report and review of the literature.
    Saad R; Ghaddar A; Zeenny RM
    J Med Case Rep; 2024 Feb; 18(1):107. PubMed ID: 38383436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP.
    Kopec M; Duma A; Helwani MA; Brown J; Brown F; Gage BF; Gibson DW; Miller JP; Novak E; Jaffe AS; Apple FS; Scott MG; Nagele P
    Anesth Analg; 2017 Feb; 124(2):398-405. PubMed ID: 28002165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between high-sensitivity cardiac troponin T and N-terminal pro-brain natriuretic peptide in a community based population.
    Xu R; Ye P; Luo L; Sheng L; Wu H; Xiao W; Zheng J; Wang F; Xiao T
    Chin Med J (Engl); 2014; 127(4):638-44. PubMed ID: 24534215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Plasma Cardiac Troponin T Levels Caused by Skeletal Muscle Damage in Pompe Disease.
    Wens SC; Schaaf GJ; Michels M; Kruijshaar ME; van Gestel TJ; In 't Groen S; Pijnenburg J; Dekkers DH; Demmers JA; Verdijk LB; Brusse E; van Schaik RH; van der Ploeg AT; van Doorn PA; Pijnappel WW
    Circ Cardiovasc Genet; 2016 Feb; 9(1):6-13. PubMed ID: 26787432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-treatment high-sensitivity troponin T for the short-term prediction of cardiac outcomes in patients on immune checkpoint inhibitors.
    Petricciuolo S; Delle Donne MG; Aimo A; Chella A; De Caterina R
    Eur J Clin Invest; 2021 Apr; 51(4):e13400. PubMed ID: 32894777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.